CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia
Clinical trial NCT04351022 · UNKNOWN
Trial details
- NCT number
- NCT04351022
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2021-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.